Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Cull

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Diabetologia|March 15, 2005
IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)G F Bottazzo, E Bosi, C A Cull, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2003
Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetesT M E Davis, Z Mehta, I R Mackay, et al.
Clinical Chemistry|October 28, 1997
Approach to maintaining comparability of biochemical data during long-term clinical trialsC A Cull, S E Manley, I M Stratton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 6, 2000
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study GroupS E Manley, I M Stratton, C A Cull, et al.
BMJ (Clinical Research Ed.)|August 11, 2000
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyI M Stratton, A I Adler, H A Neil, et al.
BMJ (Clinical Research Ed.)|August 11, 2000
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyA I Adler, I M Stratton, H A Neil, et al.
Diabetologia|February 25, 2005
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)T M E Davis, A D Wright, Z M Mehta, et al.
Diabetologia|July 28, 2007
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77M Desai, C A Cull, V A Horton, et al.
Diabetologia|November 11, 2006
Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76R Calle, M I McCarthy, P Banerjee, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Diabetologia|March 15, 2005
IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71)G F Bottazzo, E Bosi, C A Cull, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 5, 2003
Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetesT M E Davis, Z Mehta, I R Mackay, et al.
Clinical Chemistry|October 28, 1997
Approach to maintaining comparability of biochemical data during long-term clinical trialsC A Cull, S E Manley, I M Stratton, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 6, 2000
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study GroupS E Manley, I M Stratton, C A Cull, et al.
BMJ (Clinical Research Ed.)|August 11, 2000
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational studyI M Stratton, A I Adler, H A Neil, et al.
BMJ (Clinical Research Ed.)|August 11, 2000
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyA I Adler, I M Stratton, H A Neil, et al.
Diabetologia|February 25, 2005
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)T M E Davis, A D Wright, Z M Mehta, et al.
Diabetologia|July 28, 2007
GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77M Desai, C A Cull, V A Horton, et al.
Diabetologia|November 11, 2006
Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76R Calle, M I McCarthy, P Banerjee, et al.
Pageof 3